These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8039478)

  • 41. Selective suppression of hippocampal region hyperexcitability related to seizure susceptibility in epileptic El mice by the GABA-transporter inhibitor tiagabine.
    Fueta Y; Schwarz W; Ohno K; Endo Y; Mita T
    Brain Res; 2002 Aug; 947(2):212-7. PubMed ID: 12176163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tiagabine and non-convulsive status epilepticus.
    Schapel G; Chadwick D
    Seizure; 1996 Jun; 5(2):153-6. PubMed ID: 8795133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tiagabine.
    Leach JP; Brodie MJ
    Lancet; 1998 Jan; 351(9097):203-7. PubMed ID: 9449883
    [No Abstract]   [Full Text] [Related]  

  • 44. Vigabatrin and tiagabine are pharmacologically different drugs. A pre-clinical study.
    Sills GJ; Butler E; Thompson GG; Brodie MJ
    Seizure; 1999 Oct; 8(7):404-11. PubMed ID: 10600581
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Astrocytic GABA Transporters: Pharmacological Properties and Targets for Antiepileptic Drugs.
    Schousboe A; Wellendorph P; Frølund B; Clausen RP; Krogsgaard-Larsen P
    Adv Neurobiol; 2017; 16():283-296. PubMed ID: 28828616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of tiagabine on spasticity in children with intractable epilepsy: a pilot study.
    Holden KR; Titus MO
    Pediatr Neurol; 1999 Oct; 21(4):728-30. PubMed ID: 10580885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers.
    Sofuoglu M; Mouratidis M; Yoo S; Culligan K; Kosten T
    Psychopharmacology (Berl); 2005 Sep; 181(3):504-10. PubMed ID: 15983800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety of tiagabine: summary of 53 trials.
    Leppik IE; Gram L; Deaton R; Sommerville KW
    Epilepsy Res; 1999 Feb; 33(2-3):235-46. PubMed ID: 10094434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception.
    Laughlin TM; Tram KV; Wilcox GL; Birnbaum AK
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1168-75. PubMed ID: 12183677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice.
    Łuszczki J; Swiader M; Czuczwar M; Kiś J; Czuczwar SJ
    Pharmacol Biochem Behav; 2003 May; 75(2):319-27. PubMed ID: 12873622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine.
    Sills GJ
    Epileptic Disord; 2003 Mar; 5(1):51-6. PubMed ID: 12773297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue.
    Fraser CM; Sills GJ; Butler E; Thompson GG; Lindsay K; Duncan R; Howatson A; Brodie MJ
    Epileptic Disord; 1999 Sep; 1(3):153-7. PubMed ID: 10937147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different effects of GABAergic anticonvulsants on 4-aminopyridine-induced spontaneous GABAergic hyperpolarizations of hippocampal pyramidal cells--implication for their potency in migraine therapy.
    Leniger T; Wiemann M; Bingmann D; Hufnagel A; Bonnet U
    Cephalalgia; 2000 Jul; 20(6):533-7. PubMed ID: 11075835
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tiagabine: the safety landscape.
    Leppik IE
    Epilepsia; 1995; 36 Suppl 6():S10-S13. PubMed ID: 8595787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.
    Kälviäinen R
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tiagabine.
    Pierce MW; Suzdak PD; Gustavson LE; Mengel HB; McKelvy JF; Mant T
    Epilepsy Res Suppl; 1991; 3():157-60. PubMed ID: 1777074
    [No Abstract]   [Full Text] [Related]  

  • 57. The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate.
    Andersen KE; Braestrup C; Grønwald FC; Jørgensen AS; Nielsen EB; Sonnewald U; Sørensen PO; Suzdak PD; Knutsen LJ
    J Med Chem; 1993 Jun; 36(12):1716-25. PubMed ID: 8510100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [GABA-ergic system and antiepileptic drugs].
    Czuczwar SJ
    Neurol Neurochir Pol; 2000; 34 Suppl 1():13-20. PubMed ID: 10768141
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.
    Nielsen EB; Suzdak PD; Andersen KE; Knutsen LJ; Sonnewald U; Braestrup C
    Eur J Pharmacol; 1991 Apr; 196(3):257-66. PubMed ID: 1832636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects.
    Krogsgaard-Larsen P; Frølund B; Frydenvang K
    Curr Pharm Des; 2000 Aug; 6(12):1193-209. PubMed ID: 10903390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.